Dimensional Fund Advisors LP Mei Pharma, Inc. Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.41 - $8.8 $3,370 - $72,336	-8,220 Reduced 4.52%	173,760 $67,000
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.65 $21,313 - $32,984	-50,746 Reduced 21.81%	181,980 $110,000
Q1 2022 May 13, 2022	SELL	$0.54 - $2.74 $24,440 - $124,015	-45,261 Reduced 16.28%	232,726 $140,000
Q4 2021 Feb 09, 2022	SELL	$2.33 - $3.37 $188,268 - $272,302	-80,802 Reduced 22.52%	277,987 $742,000
Q3 2021 Nov 12, 2021	SELL	$2.52 - $2.99 $49,578 - $58,825	-19,674 Reduced 5.2%	358,789 $991,000
Q2 2021 Aug 12, 2021	BUY	$2.6 - $3.65 $700,874 - $983,919	269,567 Added 247.55%	378,463 $1.08 Million
Q1 2021 May 14, 2021	BUY	$2.73 - $4.5 $51,037 - $84,127	18,695 Added 20.73%	108,896 $374,000
Q4 2020 Feb 25, 2021	BUY	$2.6 - $3.32 $234,522 - $299,467	90,201 New	90,201 $238,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.